Vimarsana
Biggest News Aggregation in the World

Stated Edition News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Stated Edition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Stated Edition Today - Breaking & Trending Today

Bayer initiates Phase III Studies with Investigational Contrast Agent Gadoquatrane - Vimarsana News

Bayer initiates Phase III Studies with Investigational Contrast Agent Gadoquatrane

Published: July 8, 2023

Comprehensive clinical development program called QUANTI includes two Phase III studies in adults and one pediatric study investigating gadoquatrane for use in MRI across all body regions and across ages from birth to adulthood 

Source: itnonline.com
Related Topics:
United StatesMichael ForstingKonstanze DiefenbachNational Institute Of Biomedical ImagingGlobal Head Of Radiology Research DevelopmentUniversity EssenClarivate Decision Resources GroupInterventional RadiologyGlobal HeadRadiology ResearchNovel TetramericNational InstituteBiomedical ImagingMagnetic Resonance ImagingRetrieved JuneArlington MedicalImaging Market GuideStated EditionDecision Resources
Bayer initiates Phase III studies with investigational contrast agent gadoquatrane - Vimarsana News

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

Published: June 27, 2023

WHIPPANY, N.J.--(BUSINESS WIRE)--Jun 27, 2023--

Source: maryvilleforum.com
Related Topics:
United StatesMichael ForstingKonstanze DiefenbachNational Institute Of Biomedical ImagingGlobal Head Of Radiology Research DevelopmentUniversity EssenClarivate Decision Resources GroupInterventional RadiologyGlobal HeadRadiology ResearchNovel TetramericBiomedical ImagingMagnetic Resonance ImagingRetrieved JuneImaging Market GuideStated EditionDecision ResourcesBusiness WireBrain CancerMedical Diagnostic TechnologyMedical Technology
Bayer initiates Phase III studies with investigational contrast agent gadoquatrane - Vimarsana News

Bayer initiates Phase III studies with investigational contrast agent gadoquatrane

Published: June 27, 2023

WHIPPANY, N.J.--(BUSINESS WIRE)--Jun 27, 2023--

Source: valdostadailytimes.com
Related Topics:
United StatesKonstanze DiefenbachMichael ForstingClarivate Decision Resources GroupGlobal Head Of Radiology Research DevelopmentNational Institute Of Biomedical ImagingUniversity EssenInterventional RadiologyGlobal HeadRadiology ResearchNovel TetramericBiomedical ImagingMagnetic Resonance ImagingRetrieved JuneImaging Market GuideStated EditionDecision ResourcesBusiness Wire